RALLYBIO CORPORATION
Income Statement
| Line Item | FY2025 | FY2024 |
|---|---|---|
| Revenue | $858.0K | $636.0K |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $19.6M | $41.5M |
| SG&A Expense | $14.3M | $19.6M |
| Operating Income | $-33.1M | $-60.5M |
| Operating Margin | -3,853.6% | -9,511.9% |
| Interest Expense | — | — |
| Pretax Income | $-9.0M | $-55.5M |
| Income Tax Expense | $0 | $0 |
| Net Income | $-9.0M | $-57.8M |
| Net Margin | -1,046.4% | -9,084.1% |
| EPS (Basic) | $-1.59 | $-10.61 |
| EPS (Diluted) | $-1.59 | $-10.61 |
| Shares Outstanding (Basic) | 5.6M | 5.4M |
| Shares Outstanding (Diluted) | 5.6M | 5.4M |
| Dividends Per Share | — | — |